Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Infectious Disease Molecular Diagnostics Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The infectious disease molecular diagnostics market size has experienced robust expansion in recent years. It is projected to grow from $28.95 billion in 2024 to $30.46 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.2%. This market’s historical growth can be attributed to the increasing prevalence of infectious diseases, a rising demand for early and accurate diagnosis, the escalation of global outbreaks and pandemics, growing healthcare awareness and access, and increased investment in diagnostic research and technology.
The infectious disease molecular diagnostics market is anticipated to experience robust expansion over the coming years. This market is projected to reach $36.98 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the increasing uptake of point-of-care testing, a heightened emphasis on personalized medicine, greater governmental assistance for managing infectious diseases, the expansion of healthcare infrastructure in developing economies, and the rising occurrence of respiratory ailments. Key trends anticipated for this period encompass significant progress in real-time polymerase chain reaction technology, sophisticated incorporation of artificial intelligence into diagnostic platforms, the creation of multiplex testing panels, innovative portable and at-home diagnostic kits, and enhanced automation in molecular diagnostic procedures.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp
Which Drivers Are Impacting The Infectious Disease Molecular Diagnostics Market?
The infectious disease molecular diagnostics market is anticipated to expand due to the growing occurrence of infectious diseases. These diseases are conditions resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of transmission between individuals through direct or indirect contact. A key factor contributing to this escalating prevalence is globalization and increased travel, which facilitates the swift international dissemination of pathogens, transforming isolated outbreaks into worldwide health crises. Infectious disease molecular diagnostics aid in managing infectious diseases through the prompt and precise genetic detection of pathogens, thereby assisting with early diagnosis, specific treatments, and efficient outbreak containment. An example is provided by the Centers for Disease Control and Prevention, a US-based government agency, which reported in November 2023 that the United States saw 8,331 tuberculosis (TB) cases in 2022, an increase of 5.9% compared to 2021. Consequently, the rising incidence of infectious diseases is a significant impetus for the growth of the infectious disease molecular diagnostics market.
What Are The Different Segment Classifications Within The Infectious Disease Molecular Diagnostics Market?
The infectious disease molecular diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software And Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Mass Spectrometry, Transcription Mediated Amplification, Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services
Which Key Trends Are Expected To Influence The Infectious Disease Molecular Diagnostics Market In The Coming Years?
Key players in the infectious disease molecular diagnostics market are concentrating on creating advanced solutions, including real-time polymerase chain reaction kits, to facilitate the rapid, accurate, and high-throughput identification of infectious pathogens. These real-time polymerase chain reaction (PCR) kits function as diagnostic instruments, amplifying and concurrently detecting specific genetic material from pathogens in real time, which permits the swift and precise identification of infectious diseases. As an illustration, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, unveiled Applied Biosystems TaqPath polymerase chain reaction kits intended for the detection of infectious diseases in India. These kits offer fast, highly sensitive multiplex diagnostic capabilities, enabling real-time polymerase chain reaction detection of infectious disease targets via a comprehensive workflow, spanning from ribonucleic acid extraction to diagnostic report generation, typically completed in under 4 hours. The kits incorporate multiplexed assays aimed at various genomic regions of pathogens, include internal process controls, and deliver automated data interpretation, thereby minimizing user error and boosting result reliability.
Which Key Market Players Are Investing In Expansion And Innovation Of Infectious Disease Molecular Diagnostics Market?
Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Download The Full Report For Exclusive Market Findings:
How Does The Infectious Disease Molecular Diagnostics Market Perform Across Key Geographic Regions?
North America was the largest region in the infectious disease molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Infectious Disease Molecular Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2025, By The Business Research Company
Infection Control Supplies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Infection Control Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Hospital Acquired Infection Control Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model